Conference Coverage (Retrovirus)

AIDS Vaccine From Mutant-Fingered HIV?

Published in AIDS Weekly, March 1st, 1999

Could DNA encoding HIV with mutant zinc fingers work as an AIDS vaccine'

Yes, according to monkey studies conducted at the U.S. National Cancer Institute (NCI).

Three of four animals that received the prototype vaccine remain AIDS free four to five years after challenge with pathogenic simian immunodeficiency virus (SIV).

"We created a particle that can't package its RNA," said Larry O. Arthur, director of the AIDS Vaccine Program at the NCI-Frederick Cancer Research and Development Center (NCI-FCRDC), Frederick, Maryland.

Arthur spoke in a poster discussion session at the 6th Conference on Retroviruses and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1999-03-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry